Qishenyiqi Dripping Pill for Coronary Microvascular Disease

Clinical trial NCT06699420 · RECRUITING

Trial details

NCT number: NCT06699420
Sponsor: Qilu Hospital of Shandong University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Microvascular Disease

Start date: 2023-11-08
Primary completion: 2025-12-31
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.